Insulet Total Current Liabilities 2010-2024 | PODD
- Insulet total current liabilities for the quarter ending June 30, 2024 were $0.486B, a 14.35% increase year-over-year.
- Insulet total current liabilities for 2023 were $0.451B, a 23.72% increase from 2022.
- Insulet total current liabilities for 2022 were $0.365B, a 59.4% increase from 2021.
- Insulet total current liabilities for 2021 were $0.229B, a 10.11% increase from 2020.
Insulet Annual Total Current Liabilities (Millions of US $) |
|
---|---|
2023 | $451 |
2022 | $365 |
2021 | $229 |
2020 | $208 |
2019 | $158 |
2018 | $116 |
2017 | $86 |
2016 | $56 |
2015 | $65 |
2014 | $44 |
2013 | $42 |
2012 | $48 |
2011 | $28 |
2010 | $19 |
2009 | $20 |
Insulet Quarterly Total Current Liabilities (Millions of US $) |
|
---|---|
2024-06-30 | $486 |
2024-03-31 | $432 |
2023-12-31 | $451 |
2023-09-30 | $451 |
2023-06-30 | $425 |
2023-03-31 | $383 |
2022-12-31 | $365 |
2022-09-30 | $334 |
2022-06-30 | $279 |
2022-03-31 | $215 |
2021-12-31 | $229 |
2021-09-30 | $229 |
2021-06-30 | $213 |
2021-03-31 | $186 |
2020-12-31 | $208 |
2020-09-30 | $175 |
2020-06-30 | $134 |
2020-03-31 | $130 |
2019-12-31 | $158 |
2019-09-30 | $113 |
2019-06-30 | $106 |
2019-03-31 | $114 |
2018-12-31 | $116 |
2018-09-30 | $97 |
2018-06-30 | $76 |
2018-03-31 | $82 |
2017-12-31 | $86 |
2017-09-30 | $75 |
2017-06-30 | $48 |
2017-03-31 | $39 |
2016-12-31 | $56 |
2016-09-30 | $54 |
2016-06-30 | $55 |
2016-03-31 | $50 |
2015-12-31 | $65 |
2015-09-30 | $59 |
2015-06-30 | $53 |
2015-03-31 | $47 |
2014-12-31 | $44 |
2014-09-30 | $48 |
2014-06-30 | $71 |
2014-03-31 | $43 |
2013-12-31 | $42 |
2013-09-30 | $48 |
2013-06-30 | $34 |
2013-03-31 | $43 |
2012-12-31 | $48 |
2012-09-30 | $49 |
2012-06-30 | $43 |
2012-03-31 | $33 |
2011-12-31 | $28 |
2011-09-30 | $25 |
2011-06-30 | $27 |
2011-03-31 | $17 |
2010-12-31 | $19 |
2010-09-30 | $20 |
2010-06-30 | $24 |
2010-03-31 | $18 |
2009-12-31 | $20 |
2009-09-30 | $18 |
2009-06-30 | $17 |
2009-03-31 | $20 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $16.555B | $1.697B |
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $199.879B | 25.82 |
Stryker (SYK) | United States | $137.705B | 32.18 |
Boston Scientific (BSX) | United States | $121.595B | 37.03 |
Medtronic (MDT) | Ireland | $113.026B | 16.82 |
EssilorLuxottica (ESLOY) | France | $104.378B | 0.00 |
Haleon (HLN) | United Kingdom | $48.118B | 35.17 |
Lonza Group Ag (LZAGY) | Switzerland | $45.437B | 0.00 |
ResMed (RMD) | United States | $34.974B | 30.79 |
Koninklijke Philips (PHG) | Netherlands | $29.016B | 22.05 |
Terumo (TRUMY) | Japan | $27.876B | 39.37 |
Zimmer Biomet Holdings (ZBH) | United States | $21.644B | 13.63 |
Baxter (BAX) | United States | $20.086B | 13.62 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.426B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.489B | 31.44 |
Demant (WILYY) | Denmark | $9.197B | 0.00 |
BellRing Brands (BRBR) | United States | $7.672B | 32.44 |
Lantheus Holdings (LNTH) | United States | $7.508B | 18.02 |
ICU Medical (ICUI) | United States | $4.304B | 41.08 |
TG Therapeutics (TGTX) | United States | $3.909B | 41.39 |
Haemonetics (HAE) | United States | $3.870B | 19.14 |
Perrigo (PRGO) | Ireland | $3.841B | 12.14 |
GN Store Nord (GNNDY) | Denmark | $3.758B | 22.64 |
Neogen (NEOG) | United States | $3.736B | 39.18 |
Prestige Consumer Healthcare (PBH) | United States | $3.644B | 18.16 |
Envista Holdings (NVST) | United States | $3.298B | 17.60 |
QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
Agios Pharmaceuticals (AGIO) | United States | $2.591B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.311B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.171B | 36.43 |
LeMaitre Vascular (LMAT) | United States | $1.996B | 53.20 |
AdaptHealth (AHCO) | United States | $1.524B | 11.00 |
InMode (INMD) | Israel | $1.466B | 9.34 |
Warby Parker (WRBY) | United States | $1.466B | 0.00 |
AtriCure (ATRC) | United States | $1.363B | 0.00 |
Owens & Minor (OMI) | United States | $1.219B | 9.41 |
Verano Holdings (VRNOF) | United States | $1.114B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.094B | 0.00 |
Evolus (EOLS) | United States | $1.023B | 0.00 |
PetIQ (PETQ) | United States | $0.920B | 23.32 |
Phibro Animal Health (PAHC) | United States | $0.897B | 18.61 |
National Vision Holdings (EYE) | United States | $0.864B | 27.48 |
Cresco Labs (CRLBF) | United States | $0.801B | 0.00 |
Surmodics (SRDX) | United States | $0.561B | 119.09 |
Quanterix (QTRX) | United States | $0.543B | 0.00 |
ZimVie (ZIMV) | United States | $0.454B | 42.23 |
VAREX IMAGING (VREX) | United States | $0.451B | 13.62 |
Valneva SE (VALN) | France | $0.422B | 0.00 |
Canopy Growth (CGC) | Canada | $0.406B | 0.00 |
Jin Medical (ZJYL) | China | $0.397B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.333B | 0.00 |
Cerus (CERS) | United States | $0.330B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.321B | 8.29 |
Aurora Cannabis (ACB) | Canada | $0.320B | 0.00 |
Biote (BTMD) | United States | $0.319B | 14.70 |
Viemed Healthcare (VMD) | United States | $0.287B | 30.79 |
Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
Zynex (ZYXI) | United States | $0.260B | 45.44 |
Utah Medical Products (UTMD) | United States | $0.234B | 15.52 |
Ayr Wellness (AYRWF) | United States | $0.232B | 0.00 |
Omeros (OMER) | United States | $0.228B | 0.00 |
MacroGenics (MGNX) | United States | $0.207B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
High Tide (HITI) | Canada | $0.170B | 70.33 |
Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
FitLife Brands (FTLF) | United States | $0.153B | 20.62 |
Brainsway (BWAY) | Israel | $0.140B | 168.00 |
TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.125B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.124B | 0.00 |
Veru (VERU) | United States | $0.113B | 0.00 |
Fonar (FONR) | United States | $0.110B | 11.15 |
Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 24.20 |
InterCure (INCR) | Israel | $0.085B | 14.31 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.075B | 0.00 |
Modular Medical (MODD) | United States | $0.073B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.056B | 3.63 |
Exagen (XGN) | United States | $0.049B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Apyx Medical (APYX) | United States | $0.036B | 0.00 |
Bright Green (BGXX) | United States | $0.028B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.019B | 0.00 |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
Agape ATP (ATPC) | $0.008B | 0.00 | |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 20.47 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |